Compare AZ & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZ | NAGE |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 250.1M | 212.8M |
| IPO Year | 2021 | 2010 |
| Metric | AZ | NAGE |
|---|---|---|
| Price | $6.14 | $2.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $22.50 | $11.75 |
| AVG Volume (30 Days) | 394.5K | ★ 488.2K |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | $350.76 | N/A |
| Revenue Next Year | $206.51 | $16.83 |
| P/E Ratio | ★ N/A | $36.00 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $4.97 | $2.31 |
| 52 Week High | $8.73 | $7.28 |
| Indicator | AZ | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 52.16 | 29.79 |
| Support Level | $5.19 | N/A |
| Resistance Level | $6.27 | $3.61 |
| Average True Range (ATR) | 0.33 | 0.11 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 51.85 | 10.81 |
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.